Quantcast

Latest Abatacept Stories

2010-12-20 09:00:00

EXTON, Pa., Dec. 20, 2010 /PRNewswire/ -- In its recently released annual 2010 update, ChartTrends®: Biologics in Rheumatoid Arthritis, BioTrends Research Group, Inc.

2010-11-05 15:46:20

Today, individuals with lupus nephritis benefit from better treatments than a decade ago.

2010-09-28 19:00:04

Results from a 12-month multi-center clinical trial did not show therapeutic benefit of abatacept over placebo in patients with non-life threatening systemic lupus erythematosus (SLE).

2010-01-11 16:00:00

EXTON, Pa., Jan. 11 /PRNewswire/ -- BioTrends is pleased to announce the fielding of a new syndicated report, LaunchTrends®: ACTEMRA. Roche, Inc. announced that they received FDA approval for Actemra (generic name: tocilizumab) on January 8th.

2009-12-14 16:33:00

EXTON, Pa., Dec. 14 /PRNewswire/ -- BioTrends Research Group, Inc. released ChartTrends®: Biologics in Rheumatoid Arthritis, a syndicated publication offering comprehensive insight into the management of RA patients.

2009-10-07 10:39:17

Abatacept, a member of a new class of drug that targets immune cells to treat rheumatoid arthritis (RA), is effective against RA, according to a new Cochrane Systematic Review.

2009-08-06 06:00:00

WALTHAM, Mass., Aug. 6 /PRNewswire-FirstCall/ -- Repligen Corporation (Nasdaq: RGEN) today reported results for the first quarter fiscal year 2010, ended June 30, 2009. Total revenue for the quarter was $5,061,000 compared to total revenue of $13,660,000 for the first quarter of fiscal year 2009.

2009-07-22 07:00:00

WALTHAM, Mass., July 22 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that surveyed rheumatologists' perception of Bristol-Myers Squibb's Orencia is low among rheumatoid arthritis agents.

2009-05-26 12:51:12

University of Maryland researchers see potential new treatment approach in targeting immune response to virus.

2009-01-14 07:00:00

Recent Entrants Invest Heavily in Promotion to Capture Share in Mature Market, According to a New Report from Decision Resources WALTHAM, Mass., Jan.


Word of the Day
whirret
  • To give a box on the ear to.
The word 'whirret' may be onomatopoeic.